Fri, December 8, 2023
Thu, December 7, 2023
Wed, December 6, 2023
Tue, December 5, 2023
Mon, December 4, 2023
Fri, December 1, 2023
Thu, November 30, 2023

Carly Kenselaar Upgraded (TVTX) to Strong Buy and Increased Target to $10 on, Dec 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-increased-target-to-10-on-dec-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Carly Kenselaar of Citigroup, Upgraded "Travere Therapeutics, Inc." (TVTX) to Strong Buy and Increased Target from $7 to $10 on, Dec 5th, 2023.

Carly has made no other calls on TVTX in the last 4 months.



There are 8 other peers that have a rating on TVTX. Out of the 8 peers that are also analyzing TVTX, 3 agree with Carly's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $10 on, Wednesday, October 25th, 2023
  • Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023


These are the ratings of the 5 analyists that currently disagree with Carly


  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023

Publication Contributing Sources